Aleman, M <br/><br/>
Interleukin-12 amplifies the M. leprae hsp65-cytotoxic response in the presence of tumour necrosis factor-alpha and interferon-gamma generating CD56+ effector cells: interleukin-4 downregulates this effect.  [electronic resource] 

 -  Scandinavian journal of immunology  Mar 2000 
 - 262-70 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0300-9475 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-3083.2000.00675.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Bacterial Proteins<br/>CD56 Antigen--biosynthesis<br/>Cells, Cultured<br/>Chaperonin 60<br/>Chaperonins--immunology<br/>Cytotoxicity, Immunologic--immunology<br/>Down-Regulation--immunology<br/>Drug Synergism<br/>Female<br/>Humans<br/>Immune Sera--pharmacology<br/>Interferon-gamma--antagonists & inhibitors<br/>Interleukin-10--physiology<br/>Interleukin-12--immunology<br/>Interleukin-4--physiology<br/>Interphase--immunology<br/>Leprosy--immunology<br/>Leukocytes, Mononuclear--immunology<br/>Lymphocyte Activation--immunology<br/>Major Histocompatibility Complex--immunology<br/>Male<br/>Middle Aged<br/>Mycobacterium leprae--immunology<br/>Protein Binding--immunology<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors